Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Useful Links
Share This Page
Special Issue: Genomic Drugs for Cancer Therapeutics
Cancer drug development is leading the way in exploiting molecular biological and genetic data to develop 'personalized' medication. Cancer genomes strongly influence clinical responses for antitumor therapies. Numerous recent studies have incontestable the use of genomic knowledge, particularly sequence expression signatures, as clinical prognostic factors in cancer. The practice of medicine frequently faces the challenge of matching the correct therapeutic plan with the right patient, balancing relative profit with risk to bring home the bacon the foremost successful outcome. Pharmacogenomics has held a sturdy hold within the recent studies for cancer medical specialty. It has shown drastic effects within the field of carcinoma, ovarian cancer, prostate cancer, Bone Cancer, Mouth Cancer, Soft Tissue Sarcoma and several additional.
Type of articles
Research articles Review articles, Commentary, Case report, Letter to the editor, Image article etc.
Article Publication fees
The publication fees for the special issue articles are 900 USD- 861 EURO- 741 GBP.
Submission Procedure
There is no word limit or particular format for the preparing the manuscript. Our journal team will do all the styling after the article gets accepted.
E-mail us at: boneresearch@clinicalmedicaljournals.com or boneresearch@scholarlyjournals.org
or submit by registering at https://www.editorialmanager.com/medicaljournals/default.aspx
